Serum Institute to start manufacturing Sputnik vaccine in September

'The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September,' RDIF said in a statement.

Published: 13th July 2021 03:07 PM  |   Last Updated: 13th July 2021 03:07 PM   |  A+A-

The second consignment of COVID-19 vaccine Sputnik V arrives at Rajiv Gandhi International Airport in Hyderabad,

Sputnik V vaccine. (Photo | PTI)


NEW DELHI: Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday.

"The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September," RDIF said in a statement.

The parties intend to produce over 300 million doses of the vaccine in India per year, it added.

"As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun," RDIF said.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp